Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00001017 | Comparison of Fluconazole and Amphotericin B in the Treatment of Brain Infections in Patients With AIDS | PHASE3 | COMPLETED | 330 | — | — | - | - | Mar 14, 2011 | 28 | United States |
| Name | Type | Description |
|---|---|---|
| Fluconazole | DRUG | - |
| Amphotericin B | DRUG | - |
Inclusion Criteria * HIV infection documented by antibody (ELISA on two occasions or ELISA with Western blot confirmation), p24 antigen testing, or recovery of HIV in culture. Prior Medication: Required: * Minimum total dose of 15 mg/kg of amphotericin B (either alone or in combination with fluc...